Loading clinical trials...
Loading clinical trials...
Randomized Phase II Study Evaluating an Induction Chemotherapy Followed by a Concomitant Chemoradiotherapy and a Concomitant Chemoradiotherapy Followed by a Consolidation Chemotherapy Among Patients With NSCLC Stage III Not Resectable
Conditions
Interventions
Paclitaxel, vinorelbine, cisplatin
Locations
1
France
CHU Saint-Etienne Pneumologie
Saint-Etienne, France
Start Date
March 1, 2002
Completion Date
December 1, 2006
Last Updated
March 10, 2016
NCT03620669
NCT04027647
NCT05816499
NCT07150598
NCT04467801
NCT05212922
Lead Sponsor
Intergroupe Francophone de Cancerologie Thoracique
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions